The EML4-ALK fusion gene plays a key oncogenic role in NSCLC, while the genetic or epigenetic inactivation of NKX2-1 may impact the development and abnormal differentiation of NSCLC [37]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.